摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1,3,4,6,8,15-hexahydroxy-13-methyl-7,16-dioxo-7,16-dihydrodibenzo[a,o]perylene-10-carboxylic acid | 60483-09-2

中文名称
——
中文别名
——
英文名称
1,3,4,6,8,15-hexahydroxy-13-methyl-7,16-dioxo-7,16-dihydrodibenzo[a,o]perylene-10-carboxylic acid
英文别名
7,11,13,16,18,22-Hexahydroxy-24-methyl-9,20-dioxoheptacyclo[13.11.1.12,10.03,8.019,27.021,26.014,28]octacosa-1,3(8),4,6,10,12,14(28),15(27),16,18,21(26),22,24-tridecaene-5-carboxylic acid;7,11,13,16,18,22-hexahydroxy-24-methyl-9,20-dioxoheptacyclo[13.11.1.12,10.03,8.019,27.021,26.014,28]octacosa-1,3(8),4,6,10,12,14(28),15(27),16,18,21(26),22,24-tridecaene-5-carboxylic acid
1,3,4,6,8,15-hexahydroxy-13-methyl-7,16-dioxo-7,16-dihydrodibenzo[a,o]perylene-10-carboxylic acid化学式
CAS
60483-09-2
化学式
C30H16O10
mdl
——
分子量
536.451
InChiKey
ZMCNJTJBKOIRKQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.6
  • 重原子数:
    40
  • 可旋转键数:
    1
  • 环数:
    7.0
  • sp3杂化的碳原子比例:
    0.03
  • 拓扑面积:
    193
  • 氢给体数:
    7
  • 氢受体数:
    10

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1,3,4,6,8,15-hexahydroxy-13-methyl-7,16-dioxo-7,16-dihydrodibenzo[a,o]perylene-10-carboxylic acid过氧乙酸磷酸 作用下, 以 乙醇 为溶剂, 反应 1.0h, 生成 mono-[123I]iodohypericin monocarboxylic acid
    参考文献:
    名称:
    Synthesis and preliminary evaluation of mono-[123I]iodohypericin monocarboxylic acid as a necrosis avid imaging agent
    摘要:
    Hypericin monocarboxylic acid was synthesized in an overall yield of 25% in four steps and radiolabelled with iodine-123 in good yield (> 75%). The resulting mono-[I-123]iodohypericin monocarboxylic acid was evaluated in normal mice and in rats with ethanol induced liver necrosis. In this model, tracer concentration in necrotic liver tissue was 14 times higher than in the viable liver tissue as quantified by autoradiography at 24 h post injection. The results indicate the feasibility of visualization of necrotic tissue with the novel tracer. (C) 2007 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2007.04.083
  • 作为产物:
    参考文献:
    名称:
    Synthesis and preliminary evaluation of mono-[123I]iodohypericin monocarboxylic acid as a necrosis avid imaging agent
    摘要:
    Hypericin monocarboxylic acid was synthesized in an overall yield of 25% in four steps and radiolabelled with iodine-123 in good yield (> 75%). The resulting mono-[I-123]iodohypericin monocarboxylic acid was evaluated in normal mice and in rats with ethanol induced liver necrosis. In this model, tracer concentration in necrotic liver tissue was 14 times higher than in the viable liver tissue as quantified by autoradiography at 24 h post injection. The results indicate the feasibility of visualization of necrotic tissue with the novel tracer. (C) 2007 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2007.04.083
点击查看最新优质反应信息

文献信息

  • AN IMPROVED SYNTHESIS OF HYPERICIN AND RELATED COMPOUNDS
    作者:Ewa Gruszecka-Kowalik、Leon H. Zalkow
    DOI:10.1080/00304940009356746
    日期:2000.2
    quinone from the traditional medicinal plant St. John's wort (Hypericum genus) has been known for decades.l In recent years, the use of hypericin experienced a renaissance and much attention has been directed to it as a photodynamic agent possessing light-induced antiviral activity against several enveloped viruses, including human immunodeficiency virus (HIV), herpes simplex (HSV), Sindbis virus, murine
    金丝桃素 (3a),来自传统药用植物圣约翰草(金丝桃属)的天然羟基化多环醌已为人所知数十年。一种光动力剂,对几种包膜病毒具有光诱导的抗病毒活性,包括人类免疫缺陷病毒 (HIV)、单纯疱疹病毒 (HSV)、辛德毕斯病毒、鼠巨细胞病毒 (MCMV)、马传染性贫血病毒 (EIAV)。金丝桃素已被证明可光灭活蛋白激酶 C (PKC)、“琥珀酸氧化酶”、“酪氨酸蛋白激酶 (TPK)3c,并被鉴定为磷脂酰肌醇-3-激酶(PtdIns-3-激酶)抑制剂。'd 光化学,光物理学、立体化学、互变异构化、广泛的研究人员对金丝桃素的光生物学活性和生物医学应用进行了深入研究^。^ 该化合物被证明可以抑制多种肿瘤细胞类型的生长。5 金丝桃素被用作光动力疗法 (PDT) 的新型光敏剂) 和用于诊断应用。h 1957 年,Brockmann 等人发表了第一个多步合成金丝桃素 (3a),以 3,5-二甲氧基邻苯二甲酸酐和间甲酚开始。一年后,由大黄素蒽酮合成
  • Synthesis and preliminary biological evaluation of a99mTc-labeled hypericin derivative as a necrosis avid imaging agent
    作者:Humphrey Fonge、Lixin Jin、Huaijun Wang、Guy Bormans、Yicheng Ni、Alfons Verbruggen
    DOI:10.1002/jlcr.1468
    日期:2008.1
    mono-[123I]iodohypericin monocarboxylic acid are iodine-123-labeled hypericin derivatives which have shown great promise in preclinical studies as necrosis avid imaging agents in animal models of infarction. In view of the more attractive properties of a 99mTc-labeled hypericin derivative, we have synthesized a conjugate of protohypericin monocarboxylic acid with S-benzoylmercaptoacetyldiglycyl-diaminopentane
    单-[123I] 碘金丝桃素和单-[123I] 碘金丝桃素单羧酸是碘-123 标记的金丝桃素衍生物,它们在临床前研究中显示出巨大的前景,作为梗塞动物模型中的坏死狂热显像剂。鉴于 99mTc 标记的金丝桃素衍生物更具吸引力,我们以 15% 的总产率合成了原金丝桃素单羧酸与 S-苯甲酰基巯基乙酰基二氨基戊烷的缀合物。通过在 pH 10 下交换标记以 95% 的标记产率用锝-99m 标记缀合物,然后光环化以产生 99mTc-巯基乙酰二甘氨酰-1,5-二氨基戊烯金丝桃酸甲酰胺 (99mTc-13)。带负电荷的 99mTc-13 复合物通过反相高压液相色谱纯化,测得 log P7.4 为 2.36。在正常的 NMRI 小鼠中,该复合物显示出缓慢的肝胆清除,而血浆清除迅速。通过离体放射自显影、伽马计数和组织化学技术在再灌注肝梗塞大鼠中评估示踪剂。与放射性碘化金丝桃素衍生物不同,新的示踪剂在放射自显影和
  • Synthesis, in vitro cellular uptake and photo-induced antiproliferative effects of lipophilic hypericin acid derivatives
    作者:Ivo Crnolatac、Ann Huygens、Arthur van Aerschot、Roger Busson、Jef Rozenski、Peter A.M. de Witte
    DOI:10.1016/j.bmc.2005.09.003
    日期:2005.12
    a series of more lipophilic hypericins. For this purpose, a synthetic pathway to hypericin acid amides with hydrocarbon chains of different lengths stably attached by an amide bond at position C10 was explored. Hypericin acid proved inert in amide forming reactions, whereas the precursor protohypericin acid showed higher reactivity and resulted in the desired amide derivatives, which afterwards can
    金丝桃素是一种天然存在的羟基化菲戊二烯二酮,被用作用于光动力疗法的功能强大的光敏剂,以及用于荧光检测患者膀胱扁平赘生物病变的诊断工具。两种应用都基于该化合物的同质性。为了更深入地了解金丝桃素的某些理化特性会影响其同调尿特性,我们着手合成一系列更多的亲脂性金丝桃素。为此,探索了通过位置C10处的酰胺键稳定连接不同长度烃链的金丝桃素酰胺的合成途径。金丝桃素酸在形成酰胺的反应中被证明是惰性的,而原高丝素酸的前体显示出更高的反应活性并产生了所需的酰胺衍生物,然后可以很容易地转化成它们的菲oper二酮形式。用这种方法成功地合成了金丝桃素酸的己基,辛基,癸基和十二烷基酰胺。使用人类中度分化的非侵入性乳头状移行癌RT-112细胞系,评估了化合物的体外细胞吸收和光诱导的抗增殖作用。尽管更多的亲脂性酰胺被有限地吸收,但是己酰胺积累约5%。以及金丝桃素本身。从抗增殖数据可以进一步得出结论,不仅细胞摄取,而且光
  • Synthesis and preliminary evaluation of mono-[123I]iodohypericin monocarboxylic acid as a necrosis avid imaging agent
    作者:Humphrey Fonge、Lixin Jin、Huaijun Wang、Yicheng Ni、Guy Bormans、Alfons Verbruggen
    DOI:10.1016/j.bmcl.2007.04.083
    日期:2007.7
    Hypericin monocarboxylic acid was synthesized in an overall yield of 25% in four steps and radiolabelled with iodine-123 in good yield (> 75%). The resulting mono-[I-123]iodohypericin monocarboxylic acid was evaluated in normal mice and in rats with ethanol induced liver necrosis. In this model, tracer concentration in necrotic liver tissue was 14 times higher than in the viable liver tissue as quantified by autoradiography at 24 h post injection. The results indicate the feasibility of visualization of necrotic tissue with the novel tracer. (C) 2007 Elsevier Ltd. All rights reserved.
查看更多

同类化合物

苝-3,10-二酮 竹红菌乙素 痂囊腔菌素A 格孢毒素II 格孢毒素I 抑制剂C 卡弗他丁A 4,9-二羟基-6,7-二(2-羟基丙基)-1,5,8,12-四甲氧基苝-3,10-二酮 1-[3,10-二羟基-12-[2-(4-羟基苯甲酰基)氧基丙基]-2,6,7,11-四甲氧基-4,9-二氧代二萘嵌苯-1-基]丙-2-基4-羟基苯甲酸酯 1-[3,10-二羟基-12-(2-羟基丙基)-2,6,7,11-四甲氧基-4,9-二氧代二萘嵌苯-1-基]丙-2-基苯甲酸酯 (1S,12aR,12bS)-1,2,12a,12b-四氢-1,4,9,12a-四羟基-3,10-苝二酮 Dimethyl 3,10-Dihydro-2,4,6,7,9,11-hexamethoxy-3,10-dioxo-1,12-perylenediacetate Elsinochrome A Alterlosin I 4,10-dihydroxy-5,9-dihydrodinaphtho<2,1-b:1',2'-d>furan-5,9-dione Stemphyltoxin I Acetic acid 6,7,12-triacetoxy-3,10-dihydroxy-4,9-dioxo-4,9-dihydro-perylen-1-yl ester 4,9-Dihydroxy-1,6,7,12-tetramethoxy-perylene-3,10-dione 1,3,4,6,8,15-Hexahydroxy-10,13-bis-((1R,2S,5R)-2-isopropyl-5-methyl-cyclohexyloxymethyl)-dibenzo[a,o]perylene-7,16-dione 1,3,4,6,8,15-Hexahydroxy-10-((1R,2S,5R)-2-isopropyl-5-methyl-cyclohexyloxymethyl)-13-methyl-dibenzo[a,o]perylene-7,16-dione Acetic acid 4,9,12-triacetoxy-3,10-dioxo-3,10-dihydro-perylen-1-yl ester Cercosporin, pure 2,11-dihydroxy-4,6,7,9-tetramethoxy-1,12-bis-n-propyl-3,10-perylenequinone 7,19-dihydroxy-5-(2-hydroxypropyl)-21-[(2R)-2-hydroxypropyl]-6,20-dimethoxy-12,14-dioxahexacyclo[13.8.0.02,11.03,8.04,22.018,23]tricosa-1,3(8),4,6,10,15,18(23),19,21-nonaene-9,17-dione 2,11-Diamino-perylene-3,10-dione Stemphyltoxin III (3aS)-7,13-dihydroxy-1t,3c,8t,10c-tetramethyl-(3ar,10ac)-1,3,3a,8,10,10a-hexahydro-2,4,9,11-tetraoxa-dibenzo[bc,kl]coronene-6,14-dione [(2S)-1-[3,10-dihydroxy-12-[(2S)-2-(4-hydroxyphenoxy)carbonyloxypropyl]-2,6,7,11-tetramethoxy-4,9-dioxoperylen-1-yl]propan-2-yl] benzoate 2,4,6,7,9,11-hexamethoxy-1,12-bis-propyl-3,10-perylenequinone 6-[1-(9,17-Dihydroxy-5,10,16,21-tetramethoxy-13-methyl-7,19-dioxo-12-hexacyclo[13.8.0.02,11.03,8.04,22.018,23]tricosa-1(15),2(11),3(8),4(22),5,9,12,16,18(23),20-decaenyl)ethylideneamino]hexane-1-sulfonic acid 1,2,5,6-tetrahydroxy-dibenzo[a,o]perylene-7,16-dione calphostin D Phleichrome calphostin A [6-acetyl-8-(3-acetyl-5,7-diacetyloxy-2-methyl-4-oxo-1H-naphthalen-1-yl)-4-acetyloxy-7-methyl-5-oxo-8H-naphthalen-2-yl] acetate (13S)-12-acetyl-9,13,17-trihydroxy-5,10,16,21-tetramethoxy-13-methylhexacyclo[13.8.0.02,11.03,8.04,22.018,23]tricosa-1(15),2(11),3(8),4(22),5,9,16,18(23),20-nonaene-7,19-dione 4,9-Dihydroxy-1,5,6,7,8,12-hexamethylperylene-3,10-dione Carbonic acid, 2-(12-(2-(benzoyloxy)propyl)-3,10-dihydro-4,9-dihydroxy-2,6,7,11-tetramethoxy-3,10-dioxo-1-perylenyl)-1-methylethyl 4-hydroxyphenyl ester (-)-Phleichrome 1,3,4,6,8,15-Hexahydroxy-9,14-diisopropyl-10,13-dimethoxy-dibenzo[a,o]perylene-7,16-dione 1,6-dihydroxydibenzoperylene-7,16-dione 5-[1-(9,17-Dihydroxy-5,10,16,21-tetramethoxy-13-methyl-7,19-dioxo-12-hexacyclo[13.8.0.02,11.03,8.04,22.018,23]tricosa-1(15),2(11),3(8),4(22),5,9,12,16,18(23),20-decaenyl)ethylideneamino]pentane-1-sulfonic acid 4-[1-(9,17-Dihydroxy-5,10,16,21-tetramethoxy-13-methyl-7,19-dioxo-12-hexacyclo[13.8.0.02,11.03,8.04,22.018,23]tricosa-1(15),2(11),3(8),4(22),5,9,12,16,18(23),20-decaenyl)ethylideneamino]butane-1-sulfonic acid Cercosporin (12R,13S)-12-acetyl-9,16-dihydroxy-13-[(1S)-1-hydroxyethyl]-5,10,15,20-tetramethoxyhexacyclo[12.8.0.02,11.03,8.04,21.017,22]docosa-1(14),2(11),3(8),4(21),5,9,15,17(22),19-nonaene-7,18-dione 10,13-dimethyl-1,3,4,6-tetrahydroxy-helianthrone 12-Acetyl-16-(butylamino)-9,17-dihydroxy-5,10,21-trimethoxy-13-methylhexacyclo[13.8.0.02,11.03,8.04,22.018,23]tricosa-1(15),2(11),3(8),4(22),5,9,12,16,18(23),20-decaene-7,19-dione 5,7,11,13,16,18,22,24-Octahydroxy-6,12,17,23-tetramethyloctacyclo[13.11.1.12,10.03,8.04,25.019,27.021,26.014,28]octacosa-3,5,7,10,12,14(28),15(27),16,18,21,23,25-dodecaene-9,20-dione [(2R)-1-[3,10-dihydroxy-12-[(2S)-2-(4-hydroxyphenoxy)carbonyloxypropyl]-2,6,7,11-tetramethoxy-4,9-dioxoperylen-1-yl]propan-2-yl] benzoate [(2S)-1-[3,10-dihydroxy-12-[(2R)-2-(4-hydroxyphenoxy)carbonyloxypropyl]-2,6,7,11-tetramethoxy-4,9-dioxoperylen-1-yl]propan-2-yl] benzoate